Please assess the completion status of the following clinical trial:

Trial Title: Different Lipid Emulsions in Acute Lung Injury Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion:~* Acute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspiration~* Oxygenation factor ≤ 300~* \<= 72 hours since intubation or non-invasive ventilatory support by mask at screening~* Expected need for parenteral nutrition for at least 5 days~* Male or female ≥ 18 years of age~Exclusion:~* Exclusion of pregnancy in women with child-bearing potential~* Cardiogenic pulmonary oedema~* Previous (\< 1 month) or ongoing need for corticosteroids \>0.1 mg/kg/d prednisolon-equivalent or other immune suppressive treatment~* Active or previous (\< 1 year) treatment for solid or haematologic malignancy~* Serum triglycerides \> 300 mg/dl at screening~* Alterations of coagulation (thrombocytes \<100 Giga/l), aPTT \> 60 sec, INR ≥ 2.5 without therapeutic intervention~* Autoimmune disease or HIV (according to medical history)~* Known or suspected drug abuse~* General contraindications to infusion therapy :

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): i.v. lipid emulsion for parenteral nutrition
- 2 (Type: ACTIVE_COMPARATOR): i.v. lipid emulsion for parenteral nutrition

Based on this trial design, predict the completion outcome and termination type (if applicable).